Allied Biotech Corporation (1780.TWO)

TWD 16.9

(0.0%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 720.43 Million 716.74 Million 676.75 Million 618.06 Million -
Cost of Revenue 473.99 Million 445.7 Million 418.7 Million 376.91 Million -
Gross Profit 246.43 Million 271.04 Million 258.05 Million 241.15 Million -
Operating Expenses 157.72 Million 169.26 Million 146.38 Million 137.41 Million -
Selling, General and Administrative Expenses 131.63 Million 144.7 Million 120.64 Million 112.84 Million -
Research and Development Expenses 26.09 Million 24.55 Million 25.74 Million 24.56 Million -
Other Expenses - 91.7 Million -84.48 Million 2.81 Million -
Cost and Expenses 631.71 Million 614.96 Million 565.09 Million 514.32 Million -
Operating Income 88.71 Million 198.79 Million 28.82 Million 111.69 Million -
Interest Expense 12.95 Million 11.75 Million 11.24 Million 8.99 Million 6.51 Million
Income Tax Expense 24.97 Million 38.29 Million 4.53 Million 22.05 Million -
Earnings before Tax 122.38 Million 185.03 Million 17.57 Million 101.52 Million -
Net Income 97.41 Million 146.74 Million 13.04 Million 79.47 Million -
Earnings Per Share Basic 1.01 1.54 0.14 0.84 1.13
Earnings Per Share Diluted 1.01 1.53 0.14 0.83 1.12
Weighted Average Shares Outstanding 96.44 Million 95.38 Million 95.33 Million 94.6 Million 94.84 Million
Weighted Average Shares Outstanding (Diluted) 95.97 Million 95.78 Million 95.36 Million 95.74 Million 95.11 Million
Gross Margin 0.34 0.38 0.38 0.39 -
EBIT Margin 0.28 0.38 0.14 0.28 -
Profit Margin 0.14 0.20 0.02 0.13 -
EBITDA 204.79 Million 270.54 Million 94.06 Million 173.32 Million 199.13 Million
Earnings Before Tax Margin 0.12 0.28 0.04 0.18 -

Income Statement Charts